Back to Search
Start Over
Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
- Source :
- Clinical and Molecular Hepatology, Vol 19, Iss 1, Pp 82-86 (2013)
- Publication Year :
- 2013
- Publisher :
- Korean Association for the Study of the Liver, 2013.
-
Abstract
- Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.
Details
- Language :
- English
- ISSN :
- 22872728 and 2287285X
- Volume :
- 19
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical and Molecular Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.705207ab062849ae922f9c8d25ef3dda
- Document Type :
- article
- Full Text :
- https://doi.org/10.3350/cmh.2013.19.1.82